Showing 1 - 4 of 4
Innovation policy involves trading off monopoly output and pricing in the short run in exchange for incentives for …
Persistent link: https://www.econbiz.de/10012481677
Precision medicines - therapies that rely on the use of genetic, epigenetic, and protein biomarkers - create a better match between patients with specific disease subtypes and medications that are more effective for those patients. This heterogeneity in response has implications for the decision...
Persistent link: https://www.econbiz.de/10012453687
This paper explores the economic incentives for medical procedure innovation. Using a proprietary dataset on billing … code applications for emerging medical procedures, we highlight two mechanisms that could hinder innovation. First, the … administrative hurdle of securing permanent, reimbursable billing codes substantially delays innovation diffusion. We find that …
Persistent link: https://www.econbiz.de/10012660115
Pharmaceutical innovation policy involves managing a tradeoff between high prices for new products in the short … pharmaceuticals, suggesting low(er) price markets may have different dynamics with respect to innovation policy …
Persistent link: https://www.econbiz.de/10012533304